Exclusion of patients living with HIV from cancer immune checkpoint inhibitor trials

Emerging retrospective and prospective studies indicate that immune checkpoint inhibitors (ICIs) can be safe and effective cancer treatments among people living with human immunodeficiency virus (PLWH), however this high-cancer-risk population has often been excluded from groundbreaking cancer ICI t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vora, Kruti B., Ricciuti, Biagio, Awad, Mark M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988004/
https://www.ncbi.nlm.nih.gov/pubmed/33758321
http://dx.doi.org/10.1038/s41598-021-86081-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7988004/
https://www.ncbi.nlm.nih.gov/pubmed/33758321
http://dx.doi.org/10.1038/s41598-021-86081-w

Ejemplares similares